Literature DB >> 23603216

Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples.

Genoveva C E Keustermans1, Sanne B E Hoeks, Jenny M Meerding, Berent J Prakken, Wilco de Jager.   

Abstract

Cytokines are key components of the innate and adaptive immune system. As pivotal players in the progression or regression of a pathological process, these molecules provide a window through which diseases can be monitored and can thus act as biomarkers. In order to measure cytokine levels, a plethora of protocols can be applied. These methods include bioassays, protein microarrays, high-performance liquid chromatography (HPLC), sandwich enzyme-linked immunosorbent assay (ELISA), Meso Scale Discovery (MSD) electrochemiluminescence and bead based multiplex immunoassays (MIA). Due to the interaction and activity of cytokines, multiplex immunoassays are at the forefront of cytokine analysis by allowing multiple cytokines to be measured in parallel. However, even with optimized protocols, sample standardization needs to occur before these proteins can optimally act as biomarkers. This review describes various factors influencing the levels of cytokines measured in plasma, serum, dried blood spots and tissue biopsies, focusing on sample collection and handling, long term storage and the repetitive use of samples. By analyzing how each of these factors influences protein levels, it is concluded that samples should be stored at low temperatures in order to maintain cytokine stability. In addition, within a study, sample manipulations should be kept the same, with measurement protocols being chosen for their compatibility with the research in question. By having a clear understanding of what factors influence cytokine levels and how to overcome these technical issues, minimally confounded data can be obtained and cytokines can achieve optimal biomarker activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603216     DOI: 10.1016/j.ymeth.2013.04.005

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  48 in total

1.  A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.

Authors:  Eva Zsuzsanna Hoseth; Thor Ueland; Ingrid Dieset; Rebecca Birnbaum; Joo Heon Shin; Joel Edward Kleinman; Thomas Michael Hyde; Ragni Helene Mørch; Sigrun Hope; Tove Lekva; Aurelija Judita Abraityte; Annika E Michelsen; Ingrid Melle; Lars Tjelta Westlye; Torill Ueland; Srdjan Djurovic; Pål Aukrust; Daniel R Weinberger; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.

Authors:  J A Bastarache; T Koyama; N E Wickersham; L B Ware
Journal:  J Immunol Methods       Date:  2014-04-21       Impact factor: 2.303

3.  Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).

Authors:  Sarah C Tinker; Suzan L Carmichael; Marlene Anderka; Marilyn L Browne; Kristin M Caspers Conway; Robert E Meyer; Wendy N Nembhard; Richard S Olney; Jennita Reefhuis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-04-06

4.  Inflammatory predictors of neurobehavior in very preterm infants.

Authors:  Marliese Dion Nist; Rita H Pickler; Tondi M Harrison; Deborah K Steward; Abigail B Shoben
Journal:  Early Hum Dev       Date:  2020-05-22       Impact factor: 2.079

Review 5.  Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.

Authors:  Qi Liu; Xiang Wang; Tian Xia
Journal:  Anal Bioanal Chem       Date:  2018-08-01       Impact factor: 4.142

Review 6.  Tumor-Derived Exosomes and Their Role in Cancer Progression.

Authors:  Theresa L Whiteside
Journal:  Adv Clin Chem       Date:  2016-04-07       Impact factor: 5.394

7.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

8.  Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns*.

Authors:  An N Massaro; Taeun Chang; Stephen Baumgart; Robert McCarter; Karin B Nelson; Penny Glass
Journal:  Pediatr Crit Care Med       Date:  2014-09       Impact factor: 3.624

Review 9.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

Review 10.  The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.

Authors:  Abdulmohammad Pezeshki; Inna G Ovsyannikova; Brett A McKinney; Gregory A Poland; Richard B Kennedy
Journal:  Expert Rev Vaccines       Date:  2019-02-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.